NAFDAC to get additional powers over product inspections, clinical trials in new Senate bill

From Adesuwa Tsan, Abuja

The Senate has commenced consideration of a bill that would expand the powers of the National Agency for Food and Drug Administration and Control (NAFDAC), giving it broader authority over product inspections, clinical trials, product recalls, post-market surveillance and the regulation of emerging health technologies.

Sponsored by Suleiman Sadiq, the proposed…